Pharmacy Times May 16, 2023
By Christian Olsen

Precision medicine is rooted in the reality that the way patients respond to treatment is heavily affected by their individual genetic variability, their complex biology, and external factors.

Although the pharmaceutical industry has produced some incredible blockbuster drugs, it has largely remained unremarkable at the individual patient level, with only an estimated 30% to 50% of patients fully responding to many leading conventional drugs.1 One size does not, in fact, fit all. Some treatments just don’t work for some patients. And thus, a lengthy and costly cycle of trial-and-error often ensues, which can have grave consequences for some patients. Additionally, a one-size-fits-all approach can waste tens of billions of dollars on ineffective treatments annually.2

A gradual shift toward stratified...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Technology, Wearables
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article